How important is transparency to the rare disease community? Today's full episode of Few & Far Between features Biorasi's Lindsey Rios, with guests Rebecca Stewart and Nicola Miller from Rare Revolution Magazine.
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...
"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...
On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development...